about
Advanced protein formulationsImproving monoclonal antibody selection and engineering using measurements of colloidal protein interactionsDrugs derived from phage display: from candidate identification to clinical practiceToward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool.Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platformsBiophysical properties of the clinical-stage antibody landscape.High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.A novel screening method to assess developability of antibody-like molecules.An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies.An automated immunoassay for early specificity profiling of antibodiesHigh throughput detection of antibody self-interaction by bio-layer interferometry.Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction nanoparticle spectroscopy.Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies.Emerging methods for identifying monoclonal antibodies with low propensity to self-associate during the early discovery process.In Vitro Evolution of Antibodies Inspired by In Vivo Evolution.
P2860
Q26822616-10033586-1DD3-47FD-8A5D-4C269A4B1228Q27002558-C986F8BE-F65D-474B-B078-41C01CE3C79CQ27007101-7A0F4F95-DF4C-43F2-B1DA-C81A2EB7DCEAQ34359998-88A212ED-9B7B-4C5F-8608-E387297543A5Q34991715-C83EA58F-B20A-4BC4-87DE-72791E6AFCACQ35864980-7AB70B7C-66B5-4A7C-B83C-69FC8E4B9871Q37626251-A9575C07-6D52-4B03-86E3-2E713D7CBE35Q38718094-087A517B-C80A-4F06-A6F5-D5C351BECB6DQ38876656-1550F1A1-2D6C-40A3-A4DC-2481E2B7C570Q41845586-3F3D5C2F-5A73-4B23-9EEF-A99A12DA012BQ41874335-270F593C-E402-441B-9E1E-E37DEBBDBDEFQ41880645-5EA96189-FAAD-4543-ACCF-3C909CF4C2DEQ51722272-0710146D-EC0D-46DB-AE82-033677EB65EDQ52643675-C436EC81-FAA6-4936-8806-14885E073A10Q53636388-AACF53CE-C3E3-47FE-820A-CD19094B181EQ55426539-0471F90F-4EB3-4E09-A4C9-4C72BD2EE00B
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Solubility evaluation of murine hybridoma antibodies.
@en
Solubility evaluation of murine hybridoma antibodies.
@nl
type
label
Solubility evaluation of murine hybridoma antibodies.
@en
Solubility evaluation of murine hybridoma antibodies.
@nl
prefLabel
Solubility evaluation of murine hybridoma antibodies.
@en
Solubility evaluation of murine hybridoma antibodies.
@nl
P2093
P2860
P356
P1476
Solubility evaluation of murine hybridoma antibodies.
@en
P2093
Deidra Bethea
Jill Giles-Komar
Stacey Spencer
T Shantha Raju
Yiqing Feng
P2860
P304
P356
10.4161/MABS.19869
P577
2012-04-26T00:00:00Z